AI can now predict deadly heart arrhythmias up to two weeks in advance, potentially transforming cardiac care.
Artificial intelligence could play a key role in preventing many cases of sudden cardiac death, according to a new study published in the European Heart Journal. Researchers from Inserm, Paris Cité University, and the Paris public hospital group (AP-HP), in collaboration with colleagues in the United States, have developed an artificial neural network modeled after the human brain.
By analyzing data from over 240,000 ambulatory electrocardiograms (ECGs), the AI algorithm was able to identify patients at high risk of experiencing a life-threatening arrhythmia capable of triggering cardiac arrest within two weeks—with an accuracy exceeding 70%.
Sudden cardiac death claims more than 5 million lives globally each year. Often, these fatal events occur without warning, affecting individuals with no prior diagnosis of heart disease.
This study highlights the potential of AI to significantly improve the early detection of dangerous arrhythmias, abnormal heart rhythms that can lead to sudden cardiac arrest, by identifying at-risk patients before symptoms appear.
Developing an AI That Mimics the Brain
As part of this study, a network of artificial neurons was developed by a team of engineers from the company Cardiologs (Philips group) in collaboration with the universities of Paris Cité and Harvard. What this algorithm does is imitate the functions of the human brain in order to improve the prevention of cardiac sudden death.
The researchers analyzed several million hours of heartbeats thanks to data from 240,000 ambulatory electrocardiograms collected in six countries (USA, France, UK, South Africa, India, and Czechia).
Thanks to artificial intelligence, the researchers were able to identify new weak signals that herald the risk of arrhythmia. They were particularly interested in the time needed to electrically stimulate and relax the heart ventricles during a complete cycle of cardiac contraction and relaxation.
New Predictive Signals Identified
"By analyzing their electrical signal for 24 hours, we realized that we could identify the subjects susceptible of developing a serious heart arrhythmia within the next two weeks. If left untreated, this type of arrhythmia can progress towards a fatal cardiac arrest," explains Dr. Laurent Fiorina, first author of the study, researcher at the Paris Cardiovascular Research Centre (PARCC) (Inserm/Paris Cité University)," cardiologist at Cardiovascular Institute Paris-Sud (ICPS) (Ramsay, Massy), and medical director in charge of artificial intelligence at Philips.
While the artificial neural network is still in the evaluation phase, it showed itself in this study to be capable of detecting at-risk patients in 70% of cases, and no-risk patients in 99.9% of cases.
In the future, this algorithm could be used to monitor at-risk patients in hospitals. If its performance is refined, it could also be used in devices such as ambulatory Holters that measure blood pressure to reveal hypertension risks. It could even be used in smartwatches.
A Paradigm Shift in Cardiac Risk Prediction
"What we're proposing here is a paradigm change in the prevention of sudden death, "comments Eloi Marijon, Inserm research director at PARCC (Inserm/Paris Cité University), professor of cardiology at Paris Cité University and head of the cardiology department at Georges Pompidou European Hospital AP-HP.
"Until now we'd been trying to identify patients at risk over the medium and long term, but were incapable of predicting what could happen in the minutes, hours, or days that precede a cardiac arrest. Now, thanks to artificial intelligence, we can predict these events in the very short term and potentially take action before it's too late."
The researchers now wish to conduct prospective clinical studies to test the efficacy of this model under real-world conditions.
"It's essential for this technology to be evaluated in clinical trials before being used in medical practice," insists Dr. Fiorina. "But what we've already shown is that AI has the potential to radically transform the prevention of serious arrhythmias."
Reference: "Near-term prediction of sustained ventricular arrhythmias applying artificial intelligence to single-lead ambulatory electrocardiogram" by Laurent Fiorina, Tanner Carbonati, Kumar Narayanan, Jia Li, Christine Henry, Jagmeet P Singh and Eloi Marijon, 30 March 2025, European Heart Journal.
DOI: 10.1093/eurheartj/ehaf073
News
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer
Younger generations may be aging biologically faster than those before them, and that shift could help explain rising rates of cancer at younger ages. For decades, cancer was viewed largely as a disease of [...]
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]















